arrow
Back
B

Baek‐Yeol Ryoo

Department of Oncology

64H-index
498Paper Count
1.7WCitation Count
Published Papers 151
Publication Date
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study
err2025-11-25
err0
errOAAI
errMira Kang; Won Chul Cha; Dong Hyun Sinn; Woo Kyoung Jeong; Do Young Kim; Min Ji Lee; Subin Lim; DongKyu Kim; Kyu-Pyo Kim; Baek-Yeol Ryoo; Won-Mook Choi; Kang Mo Kim; Ki-Hun Kim; Doik Lee; Eui Jun Choi; Choungwon Jung; Joohyun Kim; Jung Yong Hong
errShare
errSave
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab
err2025-09-04
err0
errOAAI
errHyung-Don Kim; Sun Jin Sym; Hong Jae Chon; Moonho Kim; Jung Hun Kang; Baek-Yeol Ryoo; Choong-kun Lee; Joohyun Hong; Hyewon Ryu; Woo Kyun Bae; Hyeyeong Kim; Hyunho Kim; Jin Won Kim; Tae-Yong Kim; Changhoon Yoo
errShare
errSave
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma
err2025-01-28
err0
PREAI
errPark, Kanghee; Lee, Hye Won; Kim, Euichang; Choi, Won-Mook; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Yoo, Changhoon; Ryoo, Baek-Yeol; Han, Seungbong; Choi, Jonggi
errShare
errSave
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus Bevacizumab
err2025-01-21
err0
errOAAI
errCheon, Jaekyung; Ryoo, Baek-Yeol; Kim, Hyung-Don; Ryu, Min-Hee; Kim, Kyu-Pyo; Kang, Beodeul; Finn, Richard S.; Chan, Stephen Lam
errShare
errSave
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials
err2024-10-17
err0
errOAAI
errHyung, Jaewon; Kang, Minsu; Kim, Ilhwan; Kim, Kyu-pyo; Ryoo, Baek-Yeol; Cheon, Jaekyung; Ryu, Hyewon; Lee, Ji Sung; Kim, Ji-Won; Choi, In Sil; Park, Jin Hyun; Abou-Alfa, Ghassan K.; Kim, Jin Won; Yoo, Changhoon
errShare
errSave
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific
err2024-10-03
err0
PREAI
errKim, Sejin; Lee, Suat Ying; Cheon, Jaekyung; Kim, Hyung-Don; Park, Young Gyu; Lee, Joycelyn Jie Xin; Ryu, Min-Hee; Ryoo, Baek-Yeol; Tai, David; Yoo, Changhoon
errShare
errSave
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer
err2024-08-16
err1
PREAI
errBang, Yeong Hak; Lee, Choong-kun; Bang, Kyunghye; Kim, Hyung-Don; Kim, Kyu-pyo; Jeong, Jae Ho; Park, Inkeun; Ryoo, Baek-Yeol; Lee, Dong Ki; Choi, Hye Jin; Chung, Taek; Jeon, Seung Hyuck; Shin, Eui-Cheol; Oum, Chiyoon; Kim, Seulki; Lim, Yoojoo; Park, Gahee; Ahn, Chang Ho; Lee, Taebum; Finn, Richard S.; Ock, Chan-Young; Shin, Jinho; Yoo, Changhoon
errShare
errSave
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC
err2024-08-13
err0
PREAI
errLim, Ho Yeong; Heo, Jeong; Peguero, Julio A.; Ryoo, Baek-Yeol; Decaens, Thomas; Barlesi, Fabrice; Moehler, Markus H.; Jehl, Genevieve; Eggleton, S. Peter; Bajars, Marcis; Gulley, James L.
errShare
errSave
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
err2024-08-01
err6
PREAI
errChan, Stephen L.; Ryoo, Baek-Yeol; Mo, Frankie; Chan, Landon L.; Cheon, Jaekyung; Li, Leung; Wong, Kwan H.; Yim, Nicole; Kim, Hyeyeong; Yoo, Changhoon
errShare
errSave
Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer
err2024-07-01
err1
errOAAI
errLee, Woohyung; Oh, Minyoung; Kim, Jae Seung; Sung, Minkyu; Hong, Kwangpyo; Kwak, Bong Jun; Park, Yejong; Jun, Eunsung; Song, Ki Byung; Hwang, Dae Wook; Lee, Jae Hoon; Yoo, Changhoon; Kim, Kyu-pyo; Park, Inkeun; Jeong, Jae Ho; Chang, Heung-Moon; Ryoo, Baek-Yeol; Lee, Jung Bok; Kim, Song Cheol
errShare
errSave
Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
err2024-06-14
err0
errOAAI
errKim, Kyu-Pyo; Kim, Kang Mo; Ryoo, Baek-Yeol; Choi, Won-Mook; Cha, Won Chul; Kang, Mira; Sinn, Dong Hyun; Goh, Myung Ji; Kim, Do Young; Lee, Min Ji; Lim, Subin; Kim, Dongkyu; Baek, Kyoungdae; Kim, Joohyun; Choi, Eui Jun; Lee, Doik; Kim, Jung-Ae; Kim, Ki-Hun
errShare
errSave
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
err2024-04-01
err19
PREAI
errYau, Thomas; Kaseb, Ahmed; Cheng, Ann-Lii; Qin, Shukui; Zhu, Andrew X.; Chan, Stephen L.; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Milwee, Steven; Wang, Zhong; Curran, Dominic; Kelley, Robin Kate; Rimassa, Lorenza
errShare
errSave
Comprehensive proteogenomic profiling and biomarker analyses in resected extrahepatic cholangiocarcinoma: A prespecified exploratory analysis of the phase 2 STAMP trial
err2024-03-22
err0
PREAI
errJeong, Hyehyun; Oh, Ji-Hye; Ahn, Hee-Sung; Ryoo, Baek-Yeol; Kim, Kyu-pyo; Jeong, Jae Ho; Park, Inkeun; Hong, Seung-Mo; Shin, Jinho; Park, Chae Won; Cho, Yoo Sook; Kim, Kyunggon; Sung, Chang Ohk; Yoo, Changhoon
errShare
errSave
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
err2024-02-19
err14
errOAAI
errKim, Hyung-Don; Jung, Seyoung; Lim, Ho Yeong; Ryoo, Baek-Yeol; Ryu, Min-Hee; Chuah, Samuel; Chon, Hong Jae; Kang, Beodeul; Hong, Jung Yong; Lee, Han Chu; Moon, Deok-Bog; Kim, Ki-Hun; Kim, Tae Won; Tai, David; Chew, Valerie; Lee, Jeong Seok; Finn, Richard S.; Koh, June-Young; Yoo, Changhoon
errShare
errSave
Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
err2024-02-19
err11
errOAAI
errKim, Joo Young; Kim, Jisup; Kim, Yong-il; Yang, Dong-Hoon; Yoo, Changhoon; Park, In Ja; Ryoo, Baek-Yeol; Ryu, Jin-Sook; Hong, Seung-Mo
errShare
errSave
Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study
errCANCER
IF5.1
err2024-01-23
err5
errOAAI
errPiscaglia, Fabio; Ikeda, Kenji; Cheng, Ann-Lii; Kudo, Masatoshi; Ikeda, Masafumi; Breder, Valery; Ryoo, Baek-Yeol; Mody, Kalgi; Ren, Min; Ramji, Zahra; Sung, Max W.
errShare
errSave
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma
err2024-01-12
err0
errOAAI
errKim, Hyung-Don; Park, Young-Gyu; Kim, Sejin; Kim, Kyu-Pyo; Park, Sook-Ryun; Ryu, Min-Hee; Ryoo, Baek-Yeol; Yoo, Changhoon
errShare
errSave
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
err2023-12-18
err3
PREAI
errShin, Yeokyeong; Moon, Bo Hyun; Ryoo, Baek-Yeol; Chang, Heung-Moon; Kim, Kyu-pyo; Hong, Yong Sang; Kim, Tae Won; Ryu, Jin-Sook; Kim, Yong-il; Yoo, Changhoon
errShare
errSave
Integrative biomarker analysis of regorafenib plus nivolumab (RegoNivo) in unresectable hepatocellular carcinoma (uHCC): A multicenter phase 2 RENOBATE trial
err2023-04-04
err0
PREAI
errKim, Hyung-Don; Jung, Seyoung; Ryoo, Baek-Yeol; Ryu, Min-Hee; Kang, Beodeul; Chon, Hong Jae; Hong, Jung Yong; Lim, Ho Yeong; Lee, Jeong Seok; Koh, June-Young; Yoo, Changhoon
errShare
errSave